Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
J Gynecol Obstet Hum Reprod ; 50(9): 102173, 2021 Nov.
Article in English | MEDLINE | ID: mdl-34082168

ABSTRACT

AIM: To evaluate the efficacy of UPA in women with fibroid induced menorrhagia. METHODS: Embase, MEDLINE, CAB Abstracts, Cochrane Central Register of Controlled Trials, PsychInfo were searched up to 18th May 2020 and updated on 7th February 2021. Randomised controlled trials evaluating the efficacy of UPA in women with fibroid induced menorrhagia were included in the study. RESULTS: Two authors independently reviewed and extracted the study data. Statistical heterogeneity was quantified using I2 statistics. Publication bias and data asymmetry was assessed by funnel plots. A meta-analysis was conducted where appropriate. Six studies were eligible for inclusion. UPA (5 mg and 10 mg) achieved statistically significant amenorrhoeic outcome when compared to placebo (p<0.00001). Increased adverse events (AE) profile was observed in the higher UPA dose, however, did not reach statistical significance. CONCLUSIONS: This review demonstrates the efficacy of UPA in achieving amenorrhoea in women with fibroid induced menorrhagia. However, the favourable dose of UPA remains inconclusive when AE profile is taken into account. Evidence remains obscure regarding liver damage and further research is warranted to attain a conclusive outcome.


Subject(s)
Leiomyoma/complications , Menorrhagia/etiology , Norpregnadienes/pharmacology , Adult , Contraceptive Agents/pharmacology , Contraceptive Agents/therapeutic use , Female , Humans , Leiomyoma/drug therapy , Menorrhagia/drug therapy , Norpregnadienes/therapeutic use , Uterine Neoplasms/drug therapy
3.
Am J Kidney Dis ; 42(1 Suppl): 66-70, 2003 Jul.
Article in English | MEDLINE | ID: mdl-12830447

ABSTRACT

BACKGROUND: Whereas clinical benefits of more frequent hemodialysis (HD) treatment are well documented, little information is available about technical aspects involved in setting up a patient's home for home HD. Technical considerations include the home infrastructure, as well as required plumbing modifications and electrical hook-ups. METHODS: Twenty home HD installations were supported for the London Daily/Nocturnal Hemodialysis Study. The Fresenius 2008H (Fresenius Medical Care, North America, Lexington, MA) HD machine was used for all home HD installations in conjunction with a Service Deionization Tank (SDI) water treatment system composed of pretreatment, purification, and posttreatment components. To ensure that SDI systems provided high-quality water and dialysate, standard bacteriological testing was performed throughout the study, and patient serum C-reactive protein (CRP) levels were tracked as an indicator of nonspecific inflammation. RESULTS: The annual number of hours of work required for each home HD installation and service/maintenance was approximately 75 and 58 hours, respectively. Water quality proved high because there were only 4 occurrences of failed endotoxin and bacterial tests; all were subsequently retested and provided satisfactory results. Serum CRP levels showed no significant difference comparing home HD patients with conventional in-center HD control patients. CONCLUSION: Although support of 20 home HD installations was economically feasible within the constraints of the London Health Sciences Centre Department of Biomedical Engineering, resources were strained by the final year of the study. This suggests that any sustained growth beyond the current study design may require a review of staffing, resources, and model of service delivery needs.


Subject(s)
Equipment Contamination/prevention & control , Hemodialysis, Home/methods , Kidney Failure, Chronic/therapy , Water Pollution/prevention & control , Water Purification , Adult , Aged , Appointments and Schedules , C-Reactive Protein/analysis , Female , Follow-Up Studies , Hemodialysis, Home/instrumentation , Housing/standards , Humans , Infections/blood , Infections/etiology , Male , Middle Aged , Ontario/epidemiology , Prospective Studies , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...